BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12730618)

  • 1. Perturbation of maleylacetoacetic acid metabolism in rats with dichloroacetic Acid-induced glutathione transferase zeta deficiency.
    Lantum HB; Cornejo J; Pierce RH; Anders MW
    Toxicol Sci; 2003 Jul; 74(1):192-202. PubMed ID: 12730618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition and recovery of rat hepatic glutathione S-transferase zeta and alteration of tyrosine metabolism following dichloroacetate exposure and withdrawal.
    Guo X; Dixit V; Liu H; Shroads AL; Henderson GN; James MO; Stacpoole PW
    Drug Metab Dispos; 2006 Jan; 34(1):36-42. PubMed ID: 16199472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of glutathione S-transferase zeta and tyrosine metabolism by dichloroacetate: a potential unifying mechanism for its altered biotransformation and toxicity.
    Cornett R; James MO; Henderson GN; Cheung J; Shroads AL; Stacpoole PW
    Biochem Biophys Res Commun; 1999 Sep; 262(3):752-6. PubMed ID: 10471397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phenylalanine-induced leucopenia in genetic and dichloroacetic acid generated deficiency of glutathione transferase Zeta.
    Theodoratos A; Tu WJ; Cappello J; Blackburn AC; Matthaei K; Board PG
    Biochem Pharmacol; 2009 Apr; 77(8):1358-63. PubMed ID: 19426674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathione transferase zeta-catalyzed bioactivation of dichloroacetic acid: reaction of glyoxylate with amino acid nucleophiles.
    Anderson WB; Board PG; Anders MW
    Chem Res Toxicol; 2004 May; 17(5):650-62. PubMed ID: 15144222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human glutathione transferase zeta.
    Board PG; Anders MW
    Methods Enzymol; 2005; 401():61-77. PubMed ID: 16399379
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deficiency of glutathione transferase zeta causes oxidative stress and activation of antioxidant response pathways.
    Blackburn AC; Matthaei KI; Lim C; Taylor MC; Cappello JY; Hayes JD; Anders MW; Board PG
    Mol Pharmacol; 2006 Feb; 69(2):650-7. PubMed ID: 16278372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A GC-MS/MS method for the quantitative analysis of low levels of the tyrosine metabolites maleylacetone, succinylacetone, and the tyrosine metabolism inhibitor dichloroacetate in biological fluids and tissues.
    Zolodz MD; Jia M; Liu H; Henderson GN; Stacpoole PW
    J Chromatogr B Analyt Technol Biomed Life Sci; 2006 Jun; 837(1-2):125-32. PubMed ID: 16713404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical localization and activity of glutathione transferase zeta (GSTZ1-1) in rat tissues.
    Lantum HB; Baggs RB; Krenitsky DM; Board PG; Anders MW
    Drug Metab Dispos; 2002 Jun; 30(6):616-25. PubMed ID: 12019185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haplotype variations in glutathione transferase zeta 1 influence the kinetics and dynamics of chronic dichloroacetate in children.
    Shroads AL; Coats BS; McDonough CW; Langaee T; Stacpoole PW
    J Clin Pharmacol; 2015 Jan; 55(1):50-5. PubMed ID: 25079374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione transferase zeta-catalyzed biotransformation of dichloroacetic acid and other alpha-haloacids.
    Tong Z; Board PG; Anders MW
    Chem Res Toxicol; 1998 Nov; 11(11):1332-8. PubMed ID: 9815194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chloral hydrate, through biotransformation to dichloroacetate, inhibits maleylacetoacetate isomerase and tyrosine catabolism in humans.
    Shroads AL; Coats BS; Langaee T; Shuster JJ; Stacpoole PW
    Drug Metab Pers Ther; 2015 Mar; 30(1):49-55. PubMed ID: 25283137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases.
    Lim CE; Matthaei KI; Blackburn AC; Davis RP; Dahlstrom JE; Koina ME; Anders MW; Board PG
    Am J Pathol; 2004 Aug; 165(2):679-93. PubMed ID: 15277241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dichloroacetic acid up-regulates hepatic glutathione synthesis via the induction of glutamate-cysteine ligase.
    Theodoratos A; Blackburn AC; Cappello J; Tummala P; Dahlstrom JE; Board PG
    Biochem Pharmacol; 2012 Feb; 83(3):427-33. PubMed ID: 22127296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of Rats to Multiple Oral Doses of Dichloroacetate Results in Upregulation of Hepatic Glutathione Transferases and NAD(P)H Dehydrogenase [Quinone] 1.
    Squirewell EJ; Mareus R; Horne LP; Stacpoole PW; James MO
    Drug Metab Dispos; 2020 Nov; 48(11):1224-1230. PubMed ID: 32873592
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantitative evaluation of dichloroacetic acid kinetics in human--a physiologically based pharmacokinetic modeling investigation.
    Li T; Schultz I; Keys DA; Campbell JL; Fisher JW
    Toxicology; 2008 Mar; 245(1-2):35-48. PubMed ID: 18242812
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutathione transferase zeta: discovery, polymorphic variants, catalysis, inactivation, and properties of Gstz1-/- mice.
    Board PG; Anders MW
    Drug Metab Rev; 2011 May; 43(2):215-25. PubMed ID: 21303221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics of the biotransformation of maleylacetone and chlorofluoroacetic acid by polymorphic variants of human glutathione transferase zeta (hGSTZ1-1).
    Lantum HB; Board PG; Anders MW
    Chem Res Toxicol; 2002 Jul; 15(7):957-63. PubMed ID: 12119007
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dichloroacetate toxicokinetics and disruption of tyrosine catabolism in B6C3F1 mice: dose-response relationships and age as a modifying factor.
    Schultz IR; Merdink JL; Gonzalez-Leon A; Bull RJ
    Toxicology; 2002 May; 173(3):229-47. PubMed ID: 11960676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutathione-dependent conversion to glyoxylate, a major pathway of dichloroacetate biotransformation in hepatic cytosol from humans and rats, is reduced in dichloroacetate-treated rats.
    James MO; Cornett R; Yan Z; Henderson GN; Stacpoole PW
    Drug Metab Dispos; 1997 Nov; 25(11):1223-7. PubMed ID: 9351896
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.